River City Biologicals Revenue and Competitors
Estimated Revenue & Valuation
- River City Biologicals's estimated annual revenue is currently $1.4M per year.
- River City Biologicals's estimated revenue per employee is $155,000
Employee Data
- River City Biologicals has 9 Employees.
- River City Biologicals grew their employee count by 0% last year.
River City Biologicals's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller | Reveal Email/Phone |
River City Biologicals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $79.1M | 510 | 6% | N/A | N/A |
#2 | $1.1M | 7 | 17% | N/A | N/A |
#3 | $4.2M | 27 | -32% | N/A | N/A |
#4 | $2M | 13 | 30% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $0.9M | 6 | 0% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $3.7M | 24 | 4% | N/A | N/A |
#9 | $0.3M | 4 | 0% | N/A | N/A |
#10 | $6M | 39 | 50% | N/A | N/A |
What Is River City Biologicals?
River City Biologicals, is a premier supplier to the cell culture industry. We help our customers accelerate life sciences research through producing the most consistent Fetal Bovine Serum in the industry. Fetal Bovine Serum contains a complex array of protein components that are required by many cells to grow which is why it has been successfully used in cell culture. Our staff and management have decades of experience. We use that leadership by producing quality products and following strict quality procedures which allows us to be approved by ISIA (International Serum Industry Association) and APHIS (Animal and Plant Health Inspection Service). We strive to understand our customer’s current and future needs, meeting their requirements, and exceeding their expectations.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 14 | -22% | N/A |
#2 | $1.5M | 17 | 6% | N/A |
#3 | $2.1M | 19 | -10% | N/A |
#4 | $4M | 21 | -52% | N/A |
#5 | $15M | 22 | -4% | N/A |